United Therapeutics (UTHR) Treasury Shares (2009 - 2026)

United Therapeutics has disclosed Treasury Shares across 18 years of filings, most recently posting $5.4 billion for Q1 2026.

• Treasury Shares for Q1 2026 came in at $5.4 billion, up 56.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 billion (up 56.62% YoY), and the FY2025 annual result was $4.3 billion, up 22.62% from the prior year.
• Treasury Shares came in at $5.4 billion for Q1 2026 at United Therapeutics, up from $4.3 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $32.8 million in Q4 2025 to a low of $90403.0 in Q3 2024.
• The 5-year median for Treasury Shares is $26.6 million (2022), against an average of $17.4 million.
• Across the five-year window, Treasury Shares changed 0.0% in 2022 and soared 56.62% in 2026, its largest moves.
• United Therapeutics' Treasury Shares stood at $2.6 billion in 2022, then changed by 0.0% to $2.6 billion in 2023, then surged by 34.71% to $3.5 billion in 2024, then advanced by 22.62% to $4.3 billion in 2025, then increased by 27.73% to $5.4 billion in 2026.
• The last three Treasury Shares figures came in at $5.4 billion (Q1 2026), $4.3 billion (Q4 2025), and $4.3 billion (Q3 2025), per Business Quant data.